viewGoPro Inc

GoPro surges on bright second quarter results and outlook

The net loss for the three months ended 30 June narrowed dramatically to US$30.5mln, compared with a loss of almost US$92mln for the same period in 2016

go pro on a helmet
GoPro has struggled to convince people to shell out hundreds of dollars on a camera when they can use their smartphone at no extra cost

Shares in GoPro Inc (NASDAQ:GPRO) soared in early deals on Friday after the wearable video camera maker beat Wall Street forecasts with a smaller-than-expected second quarter loss.

The net loss for the three months ended 30 June narrowed dramatically to US$30.5mln, compared with a loss of almost US$92mln for the same period in 2016.

When adjusted for one-off items, the California-based group reported a US$0.09 per share loss for the quarter, much smaller than the US$0.25 analysts had been looking for.

Revenues also increased by 34% to US$296.5mln during the period, eclipsing market expectations of US$269.2mln. More than half of those sales were to customers outside of the US.

Chief executive Nicholas Woodman said “strong demand combined with cost management and margin initiatives” contributed to the improved performance.

As for the current (third) quarter, the company is guiding for a per-share loss of US$0.06 to earnings of US$0.05 on revenues of US$290-US$300mln. Analysts had estimated a loss of 12 cents a share on revenue of US$278.5mln.

Difficult couple of years

GoPro has had a torrid couple of years beset with disappointing launches, product delays and weaker demand as more and more people use their smartphones to record videos on the go.

Earlier this year, Woodman outlined plans to kick the company back into gear with various cost-cutting measures and jobs cuts.

The efforts seems to be paying off and put GoPro in a better position ahead of the release of its Hero6 and spherical Fusion camera later this year.

Wedbush still not convinced

“While first half outperformance gives us more confidence in GoPro’s potential to return to profitability, we remain somewhat skeptical due to past execution missteps and supply issues,” said Wedbush analyst Alicia Reese.

“There is no question that HERO6 will get initial orders, but we will reserve judgment about the prospects for the HERO6’s success until we see if it is well received by consumers.”

Shares gained 14.2% to US$9.43 in pre-market trade.

--Updates for share price and broker comment--

Quick facts: GoPro Inc

Price: 3.795 USD

Market: NASDAQ
Market Cap: $592 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: TRACON Pharmaceuticals reveals its low-cost drug development...

TRACON Pharmaceuticals (NASDAQ:TCON) CEO Charles Theuer tells Proactive the biotechnology company ended 2019 with cash, cash equivalents and short-term investments of $16.4 million. Theuer explains despite engaging in five different clinical trials, three of the five company's clinical trials...

11 hours, 2 minutes ago

2 min read